Convertible Credit Line and Unsecured Convertible Note Extension #2 AgreementOrgenesis Inc. • January 18th, 2023 • Pharmaceutical preparations
This Convertible Credit Line and Unsecured Convertible Note Extension#2 Agreement (“Extension#2”) is entered into as of January 12, 2023 (the “Effective Date”), by and between Orgenesis Inc. (“Borrower”) and Yosef Dotan (“Lender”). Borrower and Lender may each be referred to herein as a “Party,” and collectively as the “Parties”
Convertible Credit Line Extension AgreementConvertible Credit Line Extension Agreement • January 18th, 2023 • Orgenesis Inc. • Pharmaceutical preparations
This Convertible Credit Line Extension Agreement (“Extension”) is entered into as of January 12, 2023 (the “Effective Date”), by and between Orgenesis Inc. (“Borrower”) and Aharon Lukach (“Lender”). Borrower and Lender may each be referred to herein as a “Party,” and collectively as the “Parties.”
Convertible Loans and Unsecured Convertible Notes Extension #2 AgreementOrgenesis Inc. • January 18th, 2023 • Pharmaceutical preparations
This Convertible Loans and Unsecured Convertible Notes Extension#2 Agreement (“Extension#2”) is entered into as of January 12, 2023 (the “Effective Date”), by and between Orgenesis Inc. (“Borrower”) and Yehuda Nir (“Lender”). Borrower and Lender may each be referred to herein as a “Party,” and collectively as the “Parties”
